Sanofi's Genzyme pays $32.59 million in criminal Seprafilm case

(Reuters) – Genzyme Corp agreed to pay $32.59 million, admit wrongdoing and enter a deferred prosecution agreement to resolve U.S. criminal charges over its marketing of the surgical implant Seprafilm, the Department of Justice said on Thursday.


Source: ReuterBusiness

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *